"Plus the latest iteration of the Gen 1 device is “significantly improved upon our original clinical prototype.”
This is exciting given that the accuracy of the original prototype - in distinguishing and locating ischemic and hemorrhagic stroke - was over 90% or thereabouts!
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-9
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.00 |
Change
0.000(0.00%) |
Mkt cap ! $171.0M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.05 | $1.99 | $107.6K | 53.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2710 | $1.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.06 | 2346 | 1 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| EMV (ASX) Chart |